A new comprehensive study from Penn State College of Medicine reveals a striking surge in pediatric mental health treatment in the United States following the COVID-19 pandemic. Analyzing 13 million health records spanning from 2018 to 2022, researchers identified a post-pandemic increase in mental health care utilization that not only recovered from initial pandemic declines but exceeded pre-pandemic levels, driven primarily by an influx of new patients.
The investigation, published in the Journal of the American Academy of Child and Adolescent Psychiatry Open, parsed data to differentiate between new patients—those receiving their first psychiatric diagnosis, medication, or therapy—and ongoing patients already engaged in care. This approach highlighted that the rise in mental health service uptake was predominantly among newly diagnosed children and adolescents rather than increased treatment intensity among existing patients.
Psychiatric medication prescriptions revealed the most pronounced growth, with first-time prescriptions jumping 35% beyond pre-pandemic baselines. Notably, antidepressant prescriptions skyrocketed among girls, surging by 137% in ages six to twelve and 65% in adolescents between thirteen and eighteen. These gender-specific trends underscore a pre-existing deterioration in youth mental health exacerbated by the pandemic, aligned with CDC reports on emotional distress among young populations.
Smaller increases were observed in prescriptions for attention-deficit/hyperactivity disorder (ADHD), with a remarkable 147% rise in stimulant medication prescriptions among children aged three to five—a demographic traditionally recommended behavioral interventions over pharmacotherapy. Researchers speculate that pandemic-related disruptions may have constrained access to non-medication treatments, leaving families with fewer options.
Despite the overall increase in service uptake, the study emphasizes persistent racial and ethnic disparities in pediatric mental health care, with telehealth expansion unable to fully bridge these gaps. Factors such as internet accessibility, transportation barriers, cultural attitudes, and systemic trust issues continue to influence equitable access, highlighting the need for targeted interventions beyond technological solutions.
This large-scale analysis provides critical insight into healthcare utilization shifts and emerging patterns in pediatric mental health treatment, reflecting both the heightened demand and structural inequalities impacting care delivery. The researchers caution that their findings represent trends among treated populations, leaving the true prevalence of mental health conditions among youth potentially underestimated, as many children do not enter formal treatment pathways.
Ongoing research from the team aims to further dissect changes in psychiatric treatment across age groups, exploring influences of medication shortages and clinical adaptations, while striving to identify and mitigate disparities in evidence-based mental health care access.
Subject of Research: People
Article Title: Post-Pandemic Trends in Pediatric Mental Health Treatment: A Nationwide Study
News Publication Date: 28-May-2026
Web References: https://doi.org/10.1016/j.jaacop.2026.04.006
Keywords: Mental health, Pediatrics, Medications, Pediatric psychiatry, COVID-19 impact
